Nurse Practitioner, Family · Amherst, NY
NPI
1275963860
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3980 Sheridan Dr
Amherst, NY, 14226
Phone (716) 250-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
586 services
Medicare patients, 2024
274
Average age 61
Drug cost, 2024
$1.7M
9,743 prescriptions
Company payments, 2025
$2,827
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kalina A Bidjov was code 99214 (office e&m - established), 406 times for 261 patients. In total Kalina A Bidjov billed 586 services in 11 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 406 | 261 | $71.00 | $29K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 96 | 29 | $38.50 | $3,696 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 27 | $10.42 | $281 |
By year: 2022 $37K for 568 services; 2023 $34K for 471 services; 2024 $35K for 586 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kalina A Bidjov prescribed most often to Medicare patients was Levetiracetam, with 1,775 prescriptions and refills. In total Kalina A Bidjov wrote 9,743 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 1,775 | 2,300 | 319 | $69K |
| Lamotrigine Generic | 986 | 1,260 | 170 | $18K |
| Gabapentin Generic | 553 | 710 | 115 | $9,849 |
| Topiramate Generic | 448 | 567 | 70 | $6,455 |
| Oxcarbazepine Generic | 325 | 458 | 63 | $23K |
| Divalproex Sodium Er Divalproex Sodium | 324 | 362 | 46 | $18K |
| Divalproex Sodium Generic | 308 | 373 | 53 | $18K |
| Carbamazepine Generic | 286 | 315 | 40 | $24K |
| Carbamazepine Er Carbamazepine | 267 | 337 | 31 | $46K |
| Phenytoin Sodium Extended Generic | 233 | 290 | 37 | $7,639 |
| Lacosamide Generic | 216 | 239 | 42 | $20K |
| Donepezil Hcl Generic | 192 | 224 | 35 | $2,286 |
| Clonazepam Generic | 192 | 202 | 54 | $1,929 |
| Lactulose Generic | 180 | 180 | 30 | $11K |
| Phenobarbital Generic | 159 | 211 | 37 | $5,291 |
Brand drugs: 719 claims; generic drugs: 8,865 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kalina A Bidjov $2,827 ($2,827 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $520.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 30 | $520 |
| Collegium Pharmaceutical, Inc. COLL | 31 | $367 |
| Jazz Pharmaceuticals Inc. JAZZ | 15 | $353 |
| LivaNova USA, Inc. LIVN | 27 | $290 |
| UCB, Inc. UCB.BR | 11 | $189 |
| SK Life Science, Inc. | 8 | $171 |
| Lundbeck LLC | 6 | $120 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $113 |
| Vertex Pharmaceuticals Incorporated VRTX | 4 | $94.02 |
| Axsome Therapeutics, Inc. AXSM | 4 | $81.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.